Bola-Amphiphilic Dendrimer Enhances Imatinib to Target Metastatic Ovarian Cancer via β‑Catenin-HRP2 Signaling Axis.

MLA

Shi, Zeyu, et al. “Bola-Amphiphilic Dendrimer Enhances Imatinib to Target Metastatic Ovarian Cancer via Β‑Catenin-HRP2 Signaling Axis.” ACS Applied Materials & Interfaces, vol. 17, no. 2, Jan. 2025, pp. 2884–98. EBSCOhost, https://doi.org/10.1021/acsami.4c12857.

APA

Shi, Z., Artemenko, M., Yu, W., Zhang, M., Yi, C., Chen, P., Lin, S., Bian, Z., Lian, B., Meng, F., Chen, J., Roussel, T., Li, Y., Chan, K. K. L., Ip, P. P. C., Lai, H.-C., To, S. K. Y., Liu, X., Peng, L., & Wong, A. S. T. (2025). Bola-Amphiphilic Dendrimer Enhances Imatinib to Target Metastatic Ovarian Cancer via β‑Catenin-HRP2 Signaling Axis. ACS Applied Materials & Interfaces, 17(2), 2884–2898. https://doi.org/10.1021/acsami.4c12857

Chicago

Shi, Zeyu, Margarita Artemenko, Weiyu Yu, Ming Zhang, Canhui Yi, Peng Chen, Shuting Lin, et al. 2025. “Bola-Amphiphilic Dendrimer Enhances Imatinib to Target Metastatic Ovarian Cancer via Β‑Catenin-HRP2 Signaling Axis.” ACS Applied Materials & Interfaces 17 (2): 2884–98. doi:10.1021/acsami.4c12857.